Related Experiment Video
Updated: Jun 24, 2025

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
Operative Complications, Vaginal Bleeding, and Practice Considerations for Patients on Testosterone Undergoing
Christine Pando1, Leah R Gerlach2, Sai Alekha Challa3
1Department of Obstetrics and Gynecology, Medical College of Wisconsin (Drs. Pando and Francis), Milwaukee, Wisconsin.
Transgender patients on testosterone undergoing gender-affirming hysterectomy face higher risks of intraoperative vaginal lacerations and increased vaginal bleeding reports. This highlights the need for updated preoperative counseling for these individuals.
Area of Science:
- Reproductive Medicine
- Endocrinology
- Surgical Oncology
Background:
- Gender-affirming hysterectomy is a key component of gender affirmation for transgender individuals.
- Understanding operative risks and healthcare utilization in this population is crucial for optimizing care.
- Testosterone therapy is commonly used by transgender men and nonbinary individuals, potentially influencing surgical outcomes.
Purpose of the Study:
- To compare operative complications and healthcare utilization between transgender patients using testosterone and cisgender controls undergoing minimally invasive hysterectomy.
- To identify specific risks associated with testosterone use in the context of gender-affirming surgery.
Main Methods:
- Retrospective cohort study comparing 88 transgender patients on testosterone with 242 cisgender controls undergoing minimally invasive hysterectomy.
- Data collected on intraoperative and postoperative complications, electronic medical record (EMR) messages, phone calls, emergency department visits, and clinic visits over 90 days.
- Healthcare utilization reasons were categorized to identify trends.
Main Results:
- Testosterone users were younger, had lower BMI, and were more likely to be nulliparous.
- Increased risk of intraoperative perineal lacerations requiring repair in the testosterone group (RR 3.3).
- Higher incidence of reported vaginal bleeding via EMR or phone calls in the testosterone group (RR 1.74); increased use of postoperative vaginal estrogen.
Conclusions:
- Preoperative testosterone use may increase the risk of intraoperative vaginal laceration and postoperative vaginal bleeding reports.
- Findings support the need for enhanced preoperative counseling regarding potential surgical risks for transgender patients on testosterone.
- This evidence contributes to the ongoing understanding of the safety profile of gender-affirming hysterectomy.
More Related Videos
07:37Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
Published on: August 16, 2024
11:53Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
Published on: May 10, 2022
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Disorders of the Female Reproductive System
Menopause
Birth Control Methods